This map shows the geographic impact of Cecilio Álamo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cecilio Álamo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cecilio Álamo more than expected).
This network shows the impact of papers produced by Cecilio Álamo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cecilio Álamo. The network helps show where Cecilio Álamo may publish in the future.
Co-authorship network of co-authors of Cecilio Álamo
This figure shows the co-authorship network connecting the top 25 collaborators of Cecilio Álamo.
A scholar is included among the top collaborators of Cecilio Álamo based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Cecilio Álamo. Cecilio Álamo is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
López‐Muñoz, Francisco, et al.. (2011). Tósigos y antídotos en la literatura cervantina: Sobre los venenos en la España tardorrenacentista. Redalyc (Universidad Autónoma del Estado de México). 28(2). 119–134.1 indexed citations
8.
López‐Muñoz, Francisco, Cecilio Álamo, & Juan D. Molina. (2010). Los vínculos psiquiátricos en la obra y vida de Cajal. Dialnet (Universidad de la Rioja). 8(36). 71–83.1 indexed citations
9.
López‐Muñoz, Francisco, et al.. (2009). La terapéutica farmacológica de los trastornos mentales en la obra de Gonzalo R. Lafora.. 9(1). 71–96.1 indexed citations
López‐Muñoz, Francisco, et al.. (2007). [The virtue of that precious balsam...: approach to Don Quixote from the psychopharmacological perspective].. PubMed. 35(3). 149–220.3 indexed citations
12.
Álamo, Cecilio. (2007). Irrupción de los genéricos en el campo de los opioides potentes de liberación retardada. Revista de la Sociedad Española del Dolor. 14(6). 397–403.1 indexed citations
López‐Muñoz, Francisco, et al.. (2006). A propósito de la locura del hidalgo Alonso Quijano en el marco de la medicina española tardorrenacentista. 22(3). 133–145.5 indexed citations
15.
López‐Muñoz, Francisco, et al.. (2004). El papel histórico de los barbitúricos en las "curas de sueño" de los trastornos psicóticos y maníacos. Psiquiatría Biológica. 11(6). 242–251.6 indexed citations
Rubio, Gabriel, et al.. (2004). [Combination therapy with reboxetine for major depression patients who are partial or nonresponders to serotonin selective reuptake inhibitors].. PubMed. 31(6). 315–24.8 indexed citations
18.
López‐Muñoz, Francisco, Cecilio Álamo, & E Cuenca. (2002). Aspectos históricos del descubrimiento y de la introducción clínica de la clorpromazina: medio siglo de psicofarmacología. 2(1). 77–107.5 indexed citations
19.
López‐Muñoz, Francisco, Cecilio Álamo, & E Cuenca. (2000). La "Década de oro" de la psicofarmacología (1950-1960): trascendencia histórica de la introducción clínica de los psicofármacos clásicos.. 4(3).13 indexed citations
20.
Alguacil, Luis F., et al.. (1996). CONTRIBUCIÓN DE LOS ESTUDIOS PRECLÍNICOS AL CONOCIMIENTO Y TERAPÉUTICA DE LA DEPRESIÓN. Psicothema. 8(3). 657–667.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.